Shanghai Pharmaceuticals Holding Co., Ltd

Sümbol: SHPMF

PNK

1.21

USD

Turuhind täna

  • 10.5395

    P/E suhe

  • -0.1533

    PEG suhe

  • 6.25B

    MRK Cap

  • 0.01%

    DIV tootlus

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Finantsaruanded

Diagrammil näete Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Shanghai Pharmaceuticals Holding Co., Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

040669.93701522390.4
22296.2
18152.8
18694.7
14842.7
11970.9
12039.8
11608.6
12978.8
13528.3
14852.7
6341.6
1229.2
1046.4
665.2
564
430.1
522.7
555.3
675.2
587.3
699.2
435.7
258.9
63.2
36.2
30.6
0

balance-sheet.row.short-term-investments

010152.29613.6-1242.8
-1226.3
-1362.9
-1434.9
0.6
4.1
0.8
0.5
0.3
2.9
2.7
3.2
7.3
9.2
35.8
62.5
115.9
92.3
43.1
3.1
50.6
100
0.7
0
0
0
0
0

balance-sheet.row.net-receivables

083736.47663465885.8
59921.7
53944.4
48324.7
35415.5
30982.1
27895.5
23605.7
18170.1
15008.5
12701.1
9322.2
3419.6
2853.3
2751.2
2582.3
2539.6
3002.4
2474.6
1923.1
1615.8
53.1
98.9
92.1
30.2
13.7
19.7
0

balance-sheet.row.inventory

036623.434460.227104
24088.3
24877.4
25024
17270
16415.8
15090.6
13088.2
10996.5
9809.7
8297.5
5040.7
1974.5
1622.8
1364.2
1191.4
1351.1
1223
1370.2
1170
824
610.9
571.3
608.5
125.3
99
73
0

balance-sheet.row.other-current-assets

01404.21403.71114.2
1256.7
1117
1234.5
1114.1
898.2
559.3
355.9
369.6
455.4
144.5
2.7
-121.4
0.1
0.1
15.3
21.5
2.5
0
0
0.3
1329.2
1201.6
1068.6
120.2
95.5
86.4
189.1

balance-sheet.row.total-current-assets

0162433.9149512.9116494.4
107562.9
98091.6
93277.9
68642.3
60266.9
55585.2
48658.3
42515
38801.9
35995.8
20707.2
6502
5522.6
4780.7
4353
4342.2
4750.5
4400.2
3768.3
3027.5
2692.4
2307.5
2028
339
244.4
209.7
189.1

balance-sheet.row.property-plant-equipment-net

01787316185.315390.7
14220.6
12717.7
10194.6
8691.6
6561.1
5693.4
4993.7
4808.9
4259.4
4039.6
3978.5
892.4
913.5
1129.5
1184.6
979.6
1033.1
1077.1
1058.1
698.4
577.2
511.2
420
217.7
223.6
203
222.3

balance-sheet.row.goodwill

011393.311335.911239
11342.3
10789.9
11345.3
6606.7
5848
4815.6
4473.4
3643.3
3172.8
2988.9
422.8
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06361.36586.76308.7
5419.1
4142
4283.2
2702.4
2767.1
1984.2
1861.6
1540.3
1406.7
1276.2
875.9
432.5
446.6
526.2
366.1
73.7
143.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.goodwill-and-intangible-assets

017754.717922.717547.6
16761.3
14931.9
15628.5
9309.1
8615.1
6799.8
6335
5183.6
4579.5
4265.1
1298.7
432.5
446.6
526.2
366.1
73.7
146.9
186.1
195.5
183.7
84.7
91.1
96.7
0.3
0.3
0.3
0

balance-sheet.row.long-term-investments

0450.51863.611778.3
8888.9
6795.3
6083.4
4802.6
4492.5
3914.6
2932.5
2845.9
2691.4
2634.7
1597.4
277.7
330.2
299.6
701.1
846.5
393.5
404.8
330.4
295.6
36.6
125.2
0
0
0
0
0

balance-sheet.row.tax-assets

01716.91534.71367.5
1359.4
1222.5
1037.9
566.3
468.3
316.3
264.6
199.8
191.7
178.6
150.2
80.3
47.4
29.1
0
0
0
86.6
50.6
88
3.1
-111.6
0
0
0
0
0

balance-sheet.row.other-non-current-assets

011743.611115.7856.9
392.5
3267.5
657.1
2332.6
2338.8
2035
1156.4
758.3
544.9
554
437
944.1
990.4
720.9
73.7
134.1
140.1
86.6
50.6
88
144.4
20.7
66.5
35.6
33.8
36.8
10.3

balance-sheet.row.total-non-current-assets

049538.74862246941.1
41622.7
38934.8
33601.5
25702.2
22475.8
18759
15682.2
13796.5
12267.1
11672
7461.8
2155
2232.9
2344.9
2325.5
2033.8
1713.6
1754.7
1634.5
1265.7
842.9
748.2
583.2
253.6
257.6
240.2
232.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.account-payables

054632.551565.541995.4
37792.2
36872.5
35148
27295.2
25985.1
24436.9
20435.9
16875.8
14574.9
12659.5
8667.7
3974.2
3096
2689.7
2061.8
1650.6
1823.1
1534.1
1377.1
965.8
687.8
698.9
718.7
62.2
56.8
36.6
0

balance-sheet.row.short-term-debt

0385243100023096.6
29107.2
24327.3
22038.7
13803.5
9646.7
10679.3
7953.1
5924.4
4900.8
5675.5
4818.4
1691.1
1919.5
1999.5
2148.3
2309.9
2057.2
1897.7
1511
1131.2
1578
1308.8
984
195.8
188.3
103.1
0

balance-sheet.row.tax-payables

01217.21440.81692.7
1478.1
1215.4
1042.2
1141.4
642.5
612
546.5
393.6
415.9
393.1
254.3
56.8
29
-0.4
19.3
-49.8
-22.7
-16.1
-14.5
6.2
-4.5
-5.7
-10.8
11.5
3.9
0.4
0

balance-sheet.row.long-term-debt-total

07336.27561.48592
2685.1
10289.9
9620.3
2958.8
2836.3
93.4
105.4
125.2
40.8
52.3
66.1
22.1
25.1
3
1.2
103.2
102.1
89.7
30.8
17.5
2.6
1.6
15.6
21.5
33.7
100.7
0

Deferred Revenue Non Current

0633.5534.62349.1
2224.1
1278.7
503.3
495.8
589.7
367.9
554.3
0.5
0.5
160.4
156.9
28.1
30.4
32.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

06291.96384.99232.4
5018.6
1188.6
2698.4
8533.1
5481.5
4310.4
3613.5
2898.7
2622.4
2521
2431.5
592.8
566.1
437.4
377.7
283.1
392.4
463
444.3
316.3
293.5
196.8
172.8
27.4
34.2
26.4
130.9

balance-sheet.row.total-non-current-liabilities

09274.69441.412545
6311.9
13032.8
11736.3
5036.8
4794.9
1109.6
1238.9
1611.6
1270.1
830.4
367.2
76.4
84.1
40.8
23.8
126.6
130.4
132.6
70.8
61.6
-9.3
1.2
22.3
21.5
33.7
100.7
94.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01550.11301.61434.3
1501
1155.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0131646.4120132.5104369.3
94444.9
87640.5
80446.1
54668.6
45908.3
40536.2
33241.4
27310.5
23368.2
21686.4
16284.8
6334.6
5665.8
5167.3
4611.7
4370.2
4403.1
4027.4
3403.2
2474.9
2550
2205.7
1897.8
306.9
313
266.9
225.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

03703.33697.52842.1
2842.1
2842.1
2842.1
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
2688.9
1992.6
569.2
569.2
569.2
474.3
474.3
474.3
474.3
316.2
316.2
229.6
229.6
153
113
58
58
58

balance-sheet.row.retained-earnings

033822.332479.928598.6
25054.4
21970.9
19330.6
16578.3
14138.4
11961
10009.3
8252.6
6718.3
5196.3
3117
437.3
304.1
263
301.1
279
286.7
282.1
168.9
154.9
123.3
32.5
64.9
17.3
0.1
0
16.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01532.11553.91565.1
1152.1
531.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

029466.429331.716353.7
16306.2
16315
16840.8
14763.6
14795.2
15280.4
15123.9
15012.3
15232.1
15193.3
4024.9
827.1
815.8
809.2
980
1004.3
1002.2
973.4
1074.5
1034.2
441.2
365.8
380.1
155.2
131
125
122.2

balance-sheet.row.total-stockholders-equity

068524.16706349359.5
45354.7
41659.1
39013.6
34030.8
31622.6
29930.3
27822.1
25953.8
24639.3
23078.5
9134.6
1833.5
1689.1
1641.4
1755.5
1757.6
1763.3
1729.8
1559.6
1505.3
794
627.8
598
285.6
189.1
183
196.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0211972.5198134.9163435.5
149185.7
137026.4
126879.3
94344.5
82742.7
74344.2
64340.6
56311.5
51069
47667.8
28169
8657
7755.5
7125.6
6678.6
6376.1
6464.2
6154.8
5402.8
4293.1
3535.3
3055.6
2611.2
592.5
502.1
449.8
421.8

balance-sheet.row.minority-interest

011801.910939.49706.7
9386.1
7726.9
7419.7
5645
5211.9
3877.7
3277
3047.2
3061.6
2903
2749.7
488.9
400.7
316.9
311.5
248.3
297.8
397.7
440
312.9
191.3
222.1
115.5
0
0
0
0

balance-sheet.row.total-equity

080326.178002.559066.2
54740.7
49385.9
46433.3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

010602.711477.210535.6
7662.7
5432.4
4648.6
4803.2
4496.6
3915.4
2933
2846.2
2694.4
2637.3
1600.6
285
339.3
335.5
763.6
962.4
485.8
448
333.5
346.2
136.6
125.9
55.6
0.4
0.4
0.9
0

balance-sheet.row.total-debt

045860.238561.431688.6
31792.3
34617.1
31659
16762.3
12483
10772.7
8058.5
6049.6
4941.5
5727.8
4884.5
1713.2
1944.6
2002.4
2149.6
2413.2
2159.3
1987.3
1541.9
1148.6
1580.5
1310.4
999.6
217.3
222
203.8
0

balance-sheet.row.net-debt

015342.5111609298.3
9496.1
16464.3
12964.3
1920.2
516.2
-1266.3
-3549.5
-6928.9
-8583.9
-9122.3
-1453.9
491.3
907.4
1373
1648.1
2099
1728.9
1475.1
869.8
611.9
981.3
875.4
740.7
154.2
185.8
173.2
0

Rahavoogude aruanne

Shanghai Pharmaceuticals Holding Co., Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

05166.669926274.6
5605.3
4830.7
4456.3
4057.8
3829.7
3364.4
2992
2626.6
2460.6
2446
1779
263.5
129.4
95.5
90.5
71.4
138.5
207.5
163.1
174.8
204.7
110.8
89.8

cash-flows.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4

cash-flows.row.deferred-income-tax

0-194.8-131.9165
-233.9
-217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0194.8131.9-165
233.9
217.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-4345.5-4680-3398.7
-2013.7
-2571
-3711.7
-2291.7
-2635.8
-2747.8
-2234.2
-2275.2
-2026.7
-942.8
-368.4
62.9
-104
109.2
298.3
-148.2
-242.3
-230.7
-231
-171.1
-101.2
-61.8
-464.7

cash-flows.row.account-receivables

0-6432.4-10081.4-6155.5
-4072.2
-5083.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2303.8-7111.7-3201
932.6
63.1
-2842.9
-423
-942.7
-1943.7
-1587
-1179.7
-1466.4
-1565.9
-859.2
-323.3
-270.1
-12.3
153.4
-158.7
71.3
-300
-209.9
-206.2
-39.7
75.8
-509.9

cash-flows.row.account-payables

04585.5126455792.8
1359.7
2667.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-194.8-131.9165
-233.9
-217.7
-868.8
-1868.8
-1693.1
-804.2
-647.3
-1095.4
-560.3
623.1
490.8
386.2
166.1
121.5
144.9
10.5
-313.6
69.3
-21.1
35.1
-61.5
-137.6
45.1

cash-flows.row.other-non-cash-items

02223.3208.945.6
1115.4
1877.7
1221.1
42.8
6.7
60.1
-7.1
72.3
180.3
-210
-107.2
244.6
166.1
187.8
125.1
90.7
91.2
-46.6
96.5
11.7
-7.4
72.2
70.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.acquisitions-net

0-356.622.5-1039.3
-2045.7
-693.7
-5197.5
-913.6
-1738.7
-602.7
-1083.2
-455.3
-414.2
-4017.5
-2001.5
4
111.2
20.7
218.2
270.2
341.7
176.7
56.5
157.5
142.3
0.2
0

cash-flows.row.purchases-of-investments

0-27376.7-39683.8-3147.8
-4490.9
-1041.4
-1047.6
-4461.3
-2600.6
-1887.9
-707.9
35.8
20.1
41.6
-1325.4
-6.3
-23.2
-13
-22.6
-159.4
-190.1
-344.6
-78.7
-405
-102.3
-175.8
-31.2

cash-flows.row.sales-maturities-of-investments

027861.4302673288.2
4806.1
1271.6
1331.8
5119.4
3099.4
2055.4
976.9
251
179.6
476.3
430.4
36.3
62.1
22.5
108.9
10.3
122.9
102.5
75.4
334.2
122.2
2.1
4.9

cash-flows.row.other-investing-activites

0350.6-394-997.8
3034.8
-1367.7
-836.4
-92.2
469.7
246.6
261.1
216.5
542.3
164.3
703.8
3.9
290.2
9.2
66.6
72.1
87.3
7.1
182.9
12.8
1.2
0.3
-0.1

cash-flows.row.net-cash-used-for-investing-activites

0-2491.9-12473.1-6015.6
-1705.7
-4584.3
-7692.7
-2355
-2889.5
-1908.9
-1844.6
-892.8
-401.3
-3790.4
-2743
-46.1
349.8
-173.6
1.3
-275
-234.2
-404.6
-99.8
-202.7
-120
-225.8
-196.2

cash-flows.row.debt-repayment

0-72338.3-59808.7-52214.6
-47575.5
-38340.3
-53206.6
-22044.2
-18181.3
-18367.5
-13253.9
-10475.4
-8897.8
-12753.3
-5212.4
-3352.6
-3656.8
-3091.2
-4245.5
-3786.5
-3967.5
-204.2
-289.3
-2536.2
-1871.5
-1822.2
-1445.9

cash-flows.row.common-stock-issued

0000
0
0
2624.8
21.8
905.6
301.4
17.2
35.5
55.1
0
2046.4
6.9
24.3
0
0
0
7.2
0.9
4.5
606.4
0
0
263.2

cash-flows.row.common-stock-repurchased

0000
0
0
60659.6
25613.7
18697.4
19978.7
14169.7
11301.7
7764.4
0
4038.1
3061.5
3581.5
0
0
0
4170.7
595
537.4
1427.5
0
0
1703.9

cash-flows.row.dividends-paid

0-3981.2-3093.9-2675.9
-2418.4
-2584.2
-2357.8
-1750.2
-1443.5
-1378.2
-1251.6
-1055.4
-891.2
-775.3
-545.6
-136.7
-196
-141.8
-139.2
-210.2
-128.4
-148.3
-122.9
-49.7
-126.5
-50.4
-73

cash-flows.row.other-financing-activites

076551.475041.256456.1
48732.6
38598.7
-193.7
26087.3
19366.6
20080.6
13539.5
10773.8
7707.9
24171.7
6037.1
3092.2
3556.4
2897.7
3985.6
4084.9
4177.8
595.9
541.9
2053.9
2135.9
2110.2
1935.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0231.912138.61565.6
-1261.2
-2325.8
7526.3
2314.7
647.4
636.4
-948.8
-721.6
-2026
10643.1
2325.4
-390.3
-272.1
-335.3
-399.1
88.3
89.1
244.3
134.2
74.5
137.9
237.5
680

cash-flows.row.effect-of-forex-changes-on-cash

0-5.6-12.4-50.3
-17.6
-1.6
67.4
-18.8
-2.6
10.7
2.8
-14.6
22.7
-280.8
-5.5
0.5
1.4
-1.5
2
-2.5
1.7
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

02965.94396.4561.1
3860.2
-889.3
3036.1
2589.7
-298.1
87.4
-1454.9
-655.5
-1253.8
8344.3
1263.1
228.2
364.9
-21.5
187.3
-116.2
-81.7
-159.9
135.3
-62.5
164.2
176.1
200.6

cash-flows.row.cash-at-end-of-period

027499.824533.920137.5
19576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6039.6
1197.7
969.5
607.2
501.5
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9

cash-flows.row.cash-at-beginning-of-period

024533.920137.519576.4
15716.3
16605.6
13569.4
10979.7
11277.9
11190.4
12645.4
13300.9
14554.7
6210.4
4776.5
969.5
604.7
628.7
314.2
430.5
512.2
672.1
536.8
599.2
435
258.9
58.2

cash-flows.row.operating-cash-flow

05231.54743.45061.3
6844.7
6022.4
3135.1
2648.8
1946.7
1349.2
1335.7
973.4
1150.8
1772.4
1686.1
664.1
285.7
488.9
583.1
73
61.7
0.5
100.8
65.7
146.2
164.7
-283.1

cash-flows.row.capital-expenditure

0-2970.6-2684.9-4118.8
-3010
-2753.1
-1943
-2007.3
-2119.3
-1720.5
-1291.5
-905.1
-708.9
-413.5
-550.3
-80
-90.5
-192.3
-151.6
-198.1
-254.4
-169.6
-279.4
-144.7
-141.1
-52.5
-169.9

cash-flows.row.free-cash-flow

02260.92058.5942.6
3834.7
3269.3
1192.1
641.5
-172.6
-371.3
44.2
68.4
441.9
1358.9
1135.8
584.2
195.2
296.7
431.5
-125.1
-192.7
-169.1
-178.6
-79
5.1
112.2
-453

Kasumiaruande rida

Shanghai Pharmaceuticals Holding Co., Ltd tulud muutusid võrreldes eelmise perioodiga NaN%. SHPMF brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

0260295.1231981.3215824.3
191909.2
186565.8
159084.4
130847.2
120764.7
105516.6
92398.9
78222.8
68078.1
54899.9
37411.1
19568.1
16547.8
13919.8
11410.3
10699.3
10815
9785.8
7235.7
5202
4595.3
4529.9
4413.4
339.8
321
337.4
241.3
225.7

income-statement-row.row.cost-of-revenue

0228966.9201494.9187281.1
164474
159751.7
136521.5
114122.7
106530.9
92715.3
80994.1
67980.1
58792.6
46882.2
30619.9
17851.8
15101.4
12697.8
10618.3
9997.3
9794
8774.9
6215.3
4491.7
4003.8
3970
3886.7
291.8
270.4
291.9
205.8
193.8

income-statement-row.row.gross-profit

031328.130486.428543.1
27435.2
26814.1
22562.9
16724.5
14233.8
12801.3
11404.8
10242.7
9285.5
8017.7
6791.1
1716.3
1446.4
1222
792
702
1020.9
1010.9
1020.3
710.3
591.5
559.9
526.7
48
50.6
45.5
35.4
31.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.operating-expenses

02176321705.420616.2
19297.4
18884.5
16326.3
11747
9972.3
8846.1
8010.4
7341
6617.6
5584.3
4909.4
1112.4
1095.3
956.4
630
632
925.2
850.3
843.1
544.3
413.1
379.3
380.5
20.4
20.8
15.6
9.1
6.6

income-statement-row.row.cost-and-expenses

0250729.9223200.3207897.3
183771.4
178636.2
152847.7
125869.7
116503.2
101561.4
89004.5
75321.1
65410.2
52466.5
35529.4
18964.2
16196.7
13654.2
11248.2
10629.3
10719.2
9625.1
7058.5
5036
4416.9
4349.3
4267.2
312.2
291.2
307.5
214.9
200.4

income-statement-row.row.interest-income

0-461.8438.3338.2
288.3
234
197.4
161.4
172
138
207
242.1
304.4
262.9
47.2
10.6
8.4
20.8
18.5
19.7
23.4
15.5
7.8
8.2
17.6
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-612.912.4-267.7
117.6
174.1
144.3
-23.3
484.6
522.9
547.9
185.2
271.6
187.7
183.6
-12.3
39.8
25.2
43.9
61
69.6
55.1
36.6
7.6
9.3
9.6
22
22.7
-0.3
0.4
1.4
0.7

income-statement-row.row.total-operating-expenses

0-612.9-206.3-61.7
-8.9
48.5
135
-23.3
431.9
485.2
530.2
186.5
291.8
161.4
96
-15.8
23.1
23.9
16.9
37.5
40.7
38.4
21.9
-1
3.8
0.4
19.6
-1
-0.2
0.2
1.2
-0.2

income-statement-row.row.interest-expense

018851689.31518.2
1411.9
1405.2
1204.4
875.7
645.1
613.3
584.9
413.7
472.4
461.8
213.5
113.2
156.5
141.7
127.3
47.8
36.4
52.1
30.6
13.4
55
48.3
63.7
20.9
12
8.9
3.9
2.9

income-statement-row.row.depreciation-and-amortization

02187.12222.42139.8
2137.8
1885
1169.5
840
746.1
672.6
585
549.7
536.6
479.2
382.7
93.2
94.2
96.4
69.1
59.1
74.2
70.3
72.3
50.4
50.1
43.4
21.4
-3
11.7
8.5
3.3
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

07667.29014.78205.5
7184.4
6213.9
5208.3
5228.2
4207.1
3686.6
3269.5
3074.3
2795.9
2873.7
2076.6
370.7
163.6
122.6
84.6
61.2
150.1
219.5
191.6
203.3
218.4
137.5
89.9
30.6
18.1
21.4
23
23.7

income-statement-row.row.income-before-tax

07054.38808.48143.8
7175.5
6262.5
5343.4
5204.8
4639
4171.9
3799.7
3260.8
3087.7
3035.1
2172.5
355
186.7
146.6
101.5
98.7
190.8
257.9
213.5
202.3
222.3
137.9
109.6
29.7
17.9
21.6
24.2
23.4

income-statement-row.row.income-tax-expense

01887.71816.31869.2
1570.2
1431.7
887.1
1147
809.3
807.5
807.7
634.2
627.1
589.1
393.6
91.5
57.3
51.1
40.3
25.9
52.3
50.4
50.3
27.6
17.6
27.1
19.8
1
2.6
3.2
3.6
3.6

income-statement-row.row.net-income

037685617.25093.5
4496.2
4081
3881.1
3520.6
3196.4
2877
2591.1
2242.9
2052.9
2042.2
1368.3
173.3
82
66.3
68.7
50.5
93.1
154.4
125.8
145.3
184.8
94.4
78.7
28.7
15.2
18.3
20.6
19.9

Korduma kippuv küsimus

Mis on Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) koguvara?

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) koguvara on 211972533766.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.116.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.102.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.014.

Mis on ettevõtte kogutulu?

Kogutulu on 0.029.

Mis on Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 3767999581.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 45860206958.000.

Mis on tegevuskulude arv?

Tegevuskulud on 21762997476.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.